v3.25.3
Condensed Consolidated Statements of Stockholders' Deficit (unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive (loss) Income [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2023 $ (136,206) $ 12 $ 1,350,981 $ (161) $ (1,487,038)
Beginning balance,Shares at Dec. 31, 2023   7,661,000      
Vesting of restricted stock (in shares)   158,000      
Shares issued under the employee stock purchase plan, (in shares)   77,000      
Shares issued under the employee stock purchase plan 772   772    
Issuance of common stock for financial advisory fee (in shares)   458,000      
Issuance of common stock for financial advisory fee 6,928 $ 1 6,927    
Stock-based compensation 14,562   14,562    
Unrealized (loss) gain on investments 242     242  
Foreign currency cumulative translation adjustment (303)     (303)  
Net Income (Loss) (45,642)       (45,642)
Ending balance at Sep. 30, 2024 (159,647) $ 13 1,373,242 (222) (1,532,680)
Ending balance,Shares at Sep. 30, 2024   8,354,000      
Beginning balance at Jun. 30, 2024 (132,140) $ 13 1,369,060 (605) (1,500,608)
Beginning balance,Shares at Jun. 30, 2024   8,309,000      
Vesting of restricted stock (in shares)   45,000      
Stock-based compensation 4,182   4,182    
Unrealized (loss) gain on investments 291     291  
Foreign currency cumulative translation adjustment 92     92  
Net Income (Loss) (32,072)       (32,072)
Ending balance at Sep. 30, 2024 (159,647) $ 13 1,373,242 (222) (1,532,680)
Ending balance,Shares at Sep. 30, 2024   8,354,000      
Beginning balance at Dec. 31, 2024 (186,017) $ 13 1,377,786 (356) (1,563,460)
Beginning balance,Shares at Dec. 31, 2024   8,413,000      
Vesting of restricted stock (in shares)   227,000      
Shares issued under the employee stock purchase plan, (in shares)   62,000      
Shares issued under the employee stock purchase plan 356   356    
Stock-based compensation 10,147   10,147    
Unrealized (loss) gain on investments (53)     (53)  
Foreign currency cumulative translation adjustment 150     150  
Net Income (Loss) (93,841)       (93,841)
Ending balance at Sep. 30, 2025 (269,258) $ 13 1,388,289 (259) (1,657,301)
Ending balance,Shares at Sep. 30, 2025   8,702,000      
Beginning balance at Jun. 30, 2025 (238,926) $ 13 1,385,486 (251) (1,624,174)
Beginning balance,Shares at Jun. 30, 2025   8,647,000      
Vesting of restricted stock (in shares)   55,000      
Stock-based compensation 2,803   2,803    
Unrealized (loss) gain on investments (7)     (7)  
Foreign currency cumulative translation adjustment (1)     (1)  
Net Income (Loss) (33,127)       (33,127)
Ending balance at Sep. 30, 2025 $ (269,258) $ 13 $ 1,388,289 $ (259) $ (1,657,301)
Ending balance,Shares at Sep. 30, 2025   8,702,000